Іздеу

Шығарылым
Атауы
Авторлар
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.
Monogennye formy sakharnogo diabeta
Zubkova N., Tikhonovich Y., Tyul'pakov A.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S., Biryukova E., Solovievа I.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
Latent autoimmune diabetes in adults: current concepts of risk factors, diagnosis, and therapy
Druk I., Safronova S., Kulebakina K.
Efficacy of gosogliptin in the treatment of type 2 diabetes mellitus: a clinical case
Smirnova E.
Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
Antsiferov M., Koteshkova O., Antsiferova D., Romashkina L., Golubeva Y.
Intestinal microbiota status in patients with type 2 diabetes mellitus depending on the presence of chronic pyelonephritis at pre-dialysis stages of chronic kidney disease – an observational case-control study
Sturov N., Popov S., Kobalava Z., Belikov I., Zhukov V., Lyapunova T., Meleshkevich T.
Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children
Varlamova T., Vezikova N.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I., Boeva V.
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
Vereshchagin E., Svechnikova E., Artemyeva N.
Obesity as a factor in the development of gestational diabetes mellitus
Osmanova S., Tsakhilova S., Tsarkova M., Saschenko A.
Carbohydrate metabolism disorders and osteoporosis
Alekseeva N.
Analysis of anxiety-depressive states of patients with psoriasis and diabetes mellitus
Morzhanaeva M., Shchepkina E.
Optimization of the diabetes screening questionnaire for patients with psoriasis
Morzhanaeva M., Svechnikova E.
Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes
Shchukina E., Gromenkov V., Suprun Y., Mykhailichenko E., Beryozova E., Bagriy V., Golodnikov I.
Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs
Mkrtumyan A., Markova T.
The many faces of vitamin D
Verbovoy A., Dolgikh Y., Verbovaya N.
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E., Solovyova I.
Insulin detemir and its place in the diabetes treatment: results of 15-year use
Girsh Y.
Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
Sorokina Y., Zanozin A., Zanozina O., Runov G.
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Demidova T.
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E., Antsiferov M.
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
Petunina N., Terekhova A.
Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus
Mkrtumyan A., Podachina S., Sviridova M.
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O., Molina L.
Kombinirovannaya tsitostaticheskaya i angioprotektivnaya terapiya bol'nykh psoriazom
Bakulev A., Utts S., Shtoda Y.
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A., Verbovoy A.
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.
FAKTORY RISKA RAZVITIYa OSTEOPOROZA
Akimova D.
ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA
Yuryatin A.
Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa
Antsiferov M.
GIPOGLIKEMII V PATOGENEZE SERDEChNO-SOSUDISTOGO RISKA
Ruyatkina L., Ruyatkin D., Berezovskaya G.
SOVETNIK BOLYuSA": EFFEKTIVNOE I BEZOPASNOE UPRAVLENIE POSTPRANDIAL'NOY GLIKEMIEY U PATsIENTOV NA POMPOVOY INSULINOTERAPII
Ametov A., Valitov B., Chernikova N., Antsiferov M.
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M., Galstyan G.
Pompovaya insulinoterapiya: novye tekhnologii v sovremennoy klinicheskoy praktike
Ametov A., Valitov B., Chernikova N., Antsiferov M.
PAINFUL DIABETIC POLYNEUROPATHY
Strokov I., Strokov I.
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I., Smirnova O., Smirnova O., Kononenko I.
Insulin pump - advanced menu of experienced user
Arbatskaya N., Arbatsraya N.
IRBESARTAN I NEFROPROTEKTsIYa: VLIYaNIE NA TUBULOINTERSTITsIAL'NUYu TKAN' I FUNKTsIYu POChKI V TsELOM
Arutyunov G., Oganezova L.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Trukhina L., Petunina N., Truhina L.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.
New possibilities for diabetic peripheral neuropathy treatment
Komelyagina E., Antsiferov M., Komelyagina E., Antsiferov M.
SOVREMENNYY VZGLYaD NA INSULINOTERAPIYu U BOL'NYKh SAKhARNYM DIABETOM
Ametov A., Karpova E.
MEKhANIZM DEYSTVIYa I KLINIChESKOE PRIMENENIE METFORMINA (SIOFOR®): OBZOR LITERATURY
Demidova I., Gorokhova T.
Insulin pump therapy - a way to achieve clinical and metabolic compensation of the disease in children and adolescents with type 1 diabetes mellitus
Petryaykina E., Dukhareva O., Rybkina I., Pronina E., Mikhaylova T., Garyaeva I., Mandzhieva E., Petryaikina E., Duchareva O., Ryibkina I., Pronina E., Michailova T., Garyaeva I., Mandjieva E.
Clinical cases of management of patients with type 2 diabetes mellitus using GLP-1 receptor agonists
Kanavets N., Rebrova D.
Current trends in self-monitoring of glycemic levels
Koteshkova O., Antsiferov M., Antsiferova D.
The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children
Sadykova D., Shaydullina M., Aksenova A., Galimova L.
Features of macro- and microvascular complications in patients with type 2 diabetes mellitus (observational case-control study)
Bagriy A., Stefanenko A., Mikhailichenko E., Stefanenko E., Sabelnikova Y.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.
Microcirculation disorders in diabetic patients
Zelenina T., Zemlianoi A., Salukhov V., Ismailov D.
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.
The use of the last generation insulin analogues for the control of diabetes mellitus in real clinical practice
Koteshkova O., Dukhareva O., Demidov N., Antsiferov M.
Obesity: an invisible disease
Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N., Knyshenko O., Ivanova L.
Gestational diabetes mellitus: prevention of reproductive loss
Glavnova O., Shelygin M., Salukhova A.
Possibilities of using taurine in the treatment of psychovegetative disorders in patients with type 2 diabetes mellitus
Demicheva T.
Modern topical treatment of psoriasis in diabetic patients
Lykova S., Nemchaninova O., Svechnikova E., Morzhanayeva M.
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A., Tertychnaya E.
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L., Verbovoy A.
Diabetic autonomic neuropathy: problems of diagnosis and therapy
Kurnikova I., Yurovsky A.
Features of glycemic control in patients with type 2 diabetes mellitus and chronic heart failure
Demidova T., Titova V.
Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Fedorchenko Y., Martynyuk M.
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
Murkamilov I., Aytbaev K., Yusupov F.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
Badalyan O., Savenkov A.
Vozmozhnosti primeneniya insulina detemir pri lechenii sakharnogo diabeta u beremennykh: dokazannye preimushchestva i perspektivy ispol'zovaniya
Ruyatkina L., Sorokin M.
Vliyanie Aktovegina na reparatsiyu khronicheskikh ran razlichnoy etiologii
Dibirov M., Gadzhimuradov R., Khalidov O., Kakubava M., Polyanskiy M.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A., Sharonova L., Akhmerova R.
OSOBENNOSTI SAKhAROSNIZhAYuShchEY TERAPII VO VREMYa BEREMENNOSTI
Arbatskaya N.
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M., Nazhmutdinova P., Ametov A.
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N., Ametov A., Antsiferov M.
KLINIChESKIE PREIMUShchESTVA PERVOGO ANALOGA ChELOVEChESKOGO GPP-1 LIRAGLUTIDA PRI LEChENII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Demidova I.
SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA
Ruyatkina L., Lomova A., Ruyatkin D.
Khronicheskaya serdechnaya nedostatochnost' u bol'nykh sakharnym diabetom: sovremennye predstavleniya
Ettinger O.
Nevropatiya i prediabet: eti chasy nachinayut tikat' rano
Ametov A., Lysenko M.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Petunina N.
ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY
Tabeeva G., Azimova Y., Tabeeva G., Azimova Y.
Advance - movement forward
Petunina N., Petunina N.
OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI
Demidova I., Mel'nikova E., Arbatskaya N., Ignatova N.
Insulin resistance and heart diseases: is there a relationship?
Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.
Нәтижелер 369 - 1/100 1 2 3 4 > >> 
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>